Kirby John J.
Insider CIK 1556327 · VRCA Interim CFO · IDRA VP of Finance · VPHM V.P., Chief Accounting Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VRCA Verrica Pharmaceuticals In | P Buy | 2026-08-18 | 2026-08-18 | 5,000 | $4.93 | $24.6K | 23,962 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2026-08-18 | 2026-08-18 | 5,000 | $4.93 | $24.6K | 23,962 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | A Award | 2025-12-23 | 2025-12-30 | 10,000 | — | $0 | 18,962 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy deriv | 2025-11-25 | 2025-11-25 | 884 | — | $0 | 884 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2025-11-25 | 2025-11-25 | 3,536 | $4.24 | $15.0K | 8,962 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | A Award | 2024-11-06 | 2024-11-06 | 54,267 | — | $0 | 54,267 | SEC↗ |
| ACGN Aceragen, Inc. | A Award deriv | 2023-01-20 | 2023-02-02 | 25,400 | — | $0 | 25,400 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | F Tax w/h | 2023-01-06 | 2023-01-10 | 119,957 | $0.71 | $85.2K | 316,893 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award | 2023-01-06 | 2023-01-10 | 399,218 | — | $0 | 436,850 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2022-07-06 | 2022-07-07 | 66,500 | — | $0 | 66,500 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2022-04-01 | 2022-04-04 | 41,500 | — | $0 | 41,500 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2022-01-24 | 2022-01-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | P Buy | 2021-12-17 | 2021-12-21 | 10,000 | $0.62 | $6.2K | 37,632 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2021-07-08 | 2021-07-12 | 66,500 | — | $0 | 66,500 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | S Sale | 2021-03-25 | 2021-03-29 | 6,250 | $1.42 | $8.9K | 27,632 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | S Sale | 2021-01-12 | 2021-01-12 | 1,693 | $4.22 | $7.1K | 33,882 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2021-01-08 | 2021-01-12 | 51,000 | — | $0 | 51,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | S Sale | 2021-01-05 | 2021-01-06 | 862 | $3.90 | $3.4K | 35,575 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2020-07-21 | 2020-07-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2020-01-10 | 2020-01-14 | 50,000 | — | $0 | 50,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award | 2020-01-10 | 2020-01-14 | 20,000 | — | $0 | 36,437 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | S Sale | 2020-01-07 | 2020-01-10 | 911 | $1.78 | $1.6K | 16,437 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | S Sale | 2020-01-07 | 2020-01-14 | 911 | $1.78 | $1.6K | 16,437 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2019-07-09 | 2019-07-11 | 45,500 | — | $0 | 45,500 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2019-01-03 | 2019-01-07 | 25,600 | — | $0 | 25,600 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award | 2019-01-03 | 2019-01-07 | 10,250 | — | $0 | 12,509 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 3,960 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 6,000 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 15,000 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | U Tender | 2014-01-24 | 2014-01-28 | 60 | $50.00 | $3.0K | 0 | SEC↗ |
| VPHM VIROPHARMA INC | A Award | 2014-01-24 | 2014-01-28 | 1,980 | — | $0 | 1,980 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer | 2014-01-24 | 2014-01-28 | 1,980 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | A Award deriv | 2013-06-10 | 2013-06-12 | 6,000 | — | $0 | 6,000 | SEC↗ |
| VPHM VIROPHARMA INC | A Award deriv | 2013-01-03 | 2013-01-07 | 3,960 | — | $0 | 3,960 | SEC↗ |
| VPHM VIROPHARMA INC | A Award deriv | 2012-08-20 | 2012-08-22 | 15,000 | — | $0 | 15,000 | SEC↗ |